Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


EU Taps Power Of AI To Beat Cancer In New Imaging Initiative

Executive Summary

The European Commission’s newly-launched Cancer Imaging Initiative will see sophisticated digital technologies based on artificial intelligence used to speed up medical innovations as part of its wider Beating Cancer Plan.

You may also be interested in...

Genomics England Taps Medical Imaging Firm Sectra To Bolster Cancer Research

Genomics England, a UK government-owned genomic sequencing company, has joined forces with Swedish medical imaging and cybersecurity firm Sectra to “push the boundaries” of cancer research by linking up cancer images from NHS trusts data with genomics data and AI.

Cancer Testing Industry Will Benefit As EU Accepts Need To Modernize Screening

The Council of the EU has adopted recommendations put forward by the European Commission to broaden cancer screening significantly. This is the first time EU cancer screening recommendations have been revised in some 20 years.

MedTech Europe Urges EU To Support European Health Data Space Proposal

The European Commission’s proposed Regulation on the European Health Data Space has been broadly met with optimism by MedTech Europe. While some fine-tuning is needed, the trade body believes the initiative will help align health data across the EU.


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts